Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Assaf Oron | Chief Business Officer | 2023-11-29 | 3,414 | $0.35 | $1.19kSell |
Assaf Oron | Chief Business Officer | 2023-11-29 | 5,444 | $0.40 | $2.18kSell |
Assaf Oron | Chief Business Officer | 2023-11-29 | 2,056 | $0.34 | $699.04Sell |
Assaf Oron | Chief Business Officer | 2023-05-22 | 3,192 | $0.27 | $871.42Buy |
Assaf Oron | Chief Business Officer | 2023-05-19 | 6,521 | $0.28 | $1.83kBuy |
Assaf Oron | Chief Business Officer | 2023-05-18 | 1,201 | $0.27 | $327.87Buy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
James E. Flynn | 11.06% | 6,110,098 | $2.11M | Insider |
Erez Chimovits | 8.38% | 4,626,978 | $1.60M | Insider |
Fibrosis Foundation Cystic | 8.24% | 4,552,315 | $1.58M | Insider |
Orbimed Advisors LLC | 8.18% | 4,517,589 | $1.56M | Institution |
Orbimed Israel Biofund GP Limited Partnership | 5.73% | 3,161,489 | $1.09M | Insider |
Chidozie Ugwumba | 5.43% | 2,997,025 | $1.04M | Insider |
Takeda Pharmaceutical Co Ltd | 4.47% | 2,470,935 | $854.94k | Insider |
Johnson Johnson | 3.86% | 2,133,402 | $738.16k | Institution |
Jonas Grossman | 3.77% | 2,080,217 | $719.76k | Insider |
8vc GP I LLC | 1.97% | 1,086,191 | $375.82k | Institution |